Cost-effectiveness of Paxlovid in reducing severe COVID-19 and mortality in China
Description
CONCLUSION: Under the current marketing price of Paxlovid/box (RMB 1,890), using Paxlovid was only cost-effective in people aged over 80 years old regardless of their vaccination status.
